Page last updated: 2024-08-21

psilocybin and Atypical Cluster Headache

psilocybin has been researched along with Atypical Cluster Headache in 8 studies

Research

Studies (8)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (12.50)	29.6817
2010's	1 (12.50)	24.3611
2020's	6 (75.00)	2.80

Authors

Authors	Studies
Artto, VA; De, S; Rusanen, SS; Schindler, EAD; Storvik, M	1
Cozzi, NV; D'Souza, DC; Flynn, LT; Gottschalk, CH; Lindsey, H; Luddy, C; Pittman, BP; Schindler, EAD; Sewell, RA; Zhu, Y	1
Kooijman, NI; Kramers, C; Mulleners, WM; Reuser, A; van der Wal, SEI; Vissers, KCP; Willegers, T	1
Schindler, EAD	1
Belin, AC; Fronczek, R; Gaul, C; Jensen, RH; Lund, NLT; Meisingset, T; Petersen, AS; Steinberg, A; Tfelt-Hansen, J; Tronvik, E	1
Courault, P; Demarquay, G; Lancelot, S; Zimmer, L	1
Bayat, M	1
Halpern, JH; Pope, HG; Sewell, RA	1

Reviews

6 review(s) available for psilocybin and Atypical Cluster Headache

Article	Year
Self-Reported Efficacy of Treatments in Cluster Headache: a Systematic Review of Survey Studies. Current pain and headache reports, 2022, Volume: 26, Issue:8 Topics: Cluster Headache; Humans; Lysergic Acid Diethylamide; Psilocybin; Retrospective Studies; Self Report; Surveys and Questionnaires	2022
Are psychedelics the answer to chronic pain: A review of current literature. Pain practice : the official journal of World Institute of Pain, 2023, Volume: 23, Issue:4 Topics: Chronic Pain; Cluster Headache; Hallucinogens; Humans; Lysergic Acid Diethylamide; Neoplasms; Psilocybin; Randomized Controlled Trials as Topic	2023
The Potential of Psychedelics for the Treatment of Episodic Migraine. Current pain and headache reports, 2023, Volume: 27, Issue:9 Topics: Cluster Headache; Hallucinogens; Humans; Mental Disorders; Migraine Disorders; Psilocybin	2023
Current treatment options for cluster headache: limitations and the unmet need for better and specific treatments-a consensus article. The journal of headache and pain, 2023, Sep-04, Volume: 24, Issue:1 Topics: Cluster Headache; Consensus; Europe; Humans; Lithium Compounds; Lysergic Acid Diethylamide; Oxygen; Patients; Physicians; Prednisone; Preventive Medicine; Psilocybin; Topiramate; Tryptamines; Verapamil	2023
Cluster headache: state of the art of pharmacological treatments and therapeutic perspectives. Fundamental & clinical pharmacology, 2021, Volume: 35, Issue:3 Topics: Antibodies, Monoclonal; Botulinum Toxins, Type A; Capsaicin; Carbon Dioxide; Clinical Trials as Topic; Cluster Headache; Humans; Ketamine; Lysergic Acid Diethylamide; Oxazolidinones; Psilocybin; Receptors, Calcitonin Gene-Related Peptide; Somatostatin; Tryptamines	2021
[Classic psychedelic drugs and their potential therapeutic effect]. Ugeskrift for laeger, 2017, Sep-11, Volume: 179, Issue:37 Topics: Anti-Anxiety Agents; Antidepressive Agents; Anxiety; Cluster Headache; Depression; Hallucinogens; Humans; Lysergic Acid Diethylamide; Obsessive-Compulsive Disorder; Psilocybin; Receptor, Serotonin, 5-HT2A; Substance-Related Disorders	2017

Trials

1 trial(s) available for psilocybin and Atypical Cluster Headache

Article	Year
Exploratory investigation of a patient-informed low-dose psilocybin pulse regimen in the suppression of cluster headache: Results from a randomized, double-blind, placebo-controlled trial. Headache, 2022, Volume: 62, Issue:10 Topics: Cluster Headache; Double-Blind Method; Headache; Humans; Psilocybin; Treatment Outcome	2022

Other Studies

1 other study(ies) available for psilocybin and Atypical Cluster Headache

Article	Year
Response of cluster headache to psilocybin and LSD. Neurology, 2006, Jun-27, Volume: 66, Issue:12 Topics: Adult; Cluster Headache; Female; Hallucinogens; Humans; Lysergic Acid Diethylamide; Male; Middle Aged; Psilocybin; Retrospective Studies; Severity of Illness Index; Treatment Outcome	2006